DRKS00025824
Completed
未知
Multimodal ADHD-diagnostics: a Virtual Seminar Room study - MAD-VSR
niversitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie0 sites75 target enrollmentAugust 20, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- F90
- Sponsor
- niversitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie
- Enrollment
- 75
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Significant differences were found between unmedicated patients with ADHD and healthy controls in CPT performance, head movements, distractor gaze duration, and subjective experience. In addition, CPT performance showed potential utility for investigating medication effects within the ADHD population. No differences were found in theta-beta ratio (EEG) and dorsolateral-prefrontal hemoglobin (fNIRS)-based measures of theta-beta ratio.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Normal or corrected to normal vision, sufficient knowledge of the German language. Additional inclusion criterion for arm 1 and arm 2: DSM\-5 or ICD\-10 diagnosis of ADHD
Exclusion Criteria
- •Schizophrenia and /or severe affective disorders, harmful use or dependence of psychotropic substances, severe anxiety disorders, tic disoders or severe obsessive\-compulsive disorders, severe organic diseases, epilepsy, Glaucoma, Pheochromocytoma, Porphyria, non\-adjusted thyroidal disfunction, pregnancy or breastfeeding, dreadlocks or baldness of head
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of tPCS on Paediatric ADHD ParticipantsAttention Deficit Disorder With HyperactivityNCT02323633Braingear Technologies GmbH48
Completed
Not Applicable
Validity of ADHD Subtypes Using Neuropsychological MeasureAttention-deficit/Hyperactivity DisorderNCT00494819National Taiwan University Hospital122
Unknown
Not Applicable
Contribution of Attachment and Educational Practices in the Expression of ADHD in School-aged ChildrenAttention Deficit Hyperactivity DisorderNCT04337125Queen Fabiola Children's University Hospital160
Completed
Phase 2
Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)ADHDNCT01124708Targacept Inc.134
Completed
Phase 4
Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)Attention Deficit Disorder With HyperactivityNCT00937040Ortho-McNeil Janssen Scientific Affairs, LLC357